NOX4 and metabolic dysfunction-associated steatohepatitis: Intraperitoneally injected with 5 mg/kg PD reduced oxidative stress by decreasing the levels of NOX4, ROS, and 4-hydroxynonenal (4-HNE) in MCD-induced NASH C57BL/6 mice [59].